133 related articles for article (PubMed ID: 35352855)
1. Health-care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis.
Chen YJ; Tang W; Ionescu-Ittu R; Ayyagari R; Wu E; Huh SY; Parkman HP
Neurogastroenterol Motil; 2022 Sep; 34(9):e14366. PubMed ID: 35352855
[TBL] [Abstract][Full Text] [Related]
2. Nausea and vomiting in diabetic and idiopathic gastroparesis.
Cherian D; Parkman HP
Neurogastroenterol Motil; 2012 Mar; 24(3):217-22, e103. PubMed ID: 22118574
[TBL] [Abstract][Full Text] [Related]
3. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.
To TM; Ta JT; Patel AM; Arndorfer S; Abbass IM; Gandhy R
J Med Econ; 2023; 26(1):862-870. PubMed ID: 37350423
[TBL] [Abstract][Full Text] [Related]
4. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
[TBL] [Abstract][Full Text] [Related]
5. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium.
Grover M; Bernard CE; Pasricha PJ; Lurken MS; Faussone-Pellegrini MS; Smyrk TC; Parkman HP; Abell TL; Snape WJ; Hasler WL; McCallum RW; Nguyen L; Koch KL; Calles J; Lee L; Tonascia J; Ünalp-Arida A; Hamilton FA; Farrugia G;
Neurogastroenterol Motil; 2012 Jun; 24(6):531-9, e249. PubMed ID: 22339929
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns Among Patients With Mantle Cell Lymphoma and Comparison of Healthcare Resource Utilization and Costs Among Relapsed/Refractory Patients Treated With Ibrutinib or Chemoimmunotherapy: A Real-world Retrospective Study.
Ghosh N; Emond B; Lafeuille MH; Côté-Sergent A; Lefebvre P; Huang Q
Clin Ther; 2021 Aug; 43(8):1285-1299. PubMed ID: 34332789
[TBL] [Abstract][Full Text] [Related]
7. Time duration and health care resource use during cancer diagnoses in the United States: A large claims database analysis.
Gitlin M; McGarvey N; Shivaprakash N; Cong Z
J Manag Care Spec Pharm; 2023 Jun; 29(6):659-670. PubMed ID: 37276034
[No Abstract] [Full Text] [Related]
8. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences between diabetic and idiopathic gastroparesis.
Parkman HP; Yates K; Hasler WL; Nguyen L; Pasricha PJ; Snape WJ; Farrugia G; Koch KL; Calles J; Abell TL; McCallum RW; Lee L; Unalp-Arida A; Tonascia J; Hamilton F;
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1056-64; quiz e133-4. PubMed ID: 21871247
[TBL] [Abstract][Full Text] [Related]
10. Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.
Parkman HP; Hallinan EK; Hasler WL; Farrugia G; Koch KL; Calles J; Snape WJ; Abell TL; Sarosiek I; McCallum RW; Nguyen L; Pasricha PJ; Clarke J; Miriel L; Lee L; Tonascia J; Hamilton F;
Neurogastroenterol Motil; 2016 Dec; 28(12):1902-1914. PubMed ID: 27350152
[TBL] [Abstract][Full Text] [Related]
11. Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States.
Zhdanava M; Ndife B; Pilon D; Rossi C; Vermette-Laforme M; Lefebvre P; Suh JD
Otolaryngol Head Neck Surg; 2023 Jan; 168(1):65-73. PubMed ID: 35349388
[TBL] [Abstract][Full Text] [Related]
12. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
13. Proteomics in gastroparesis: unique and overlapping protein signatures in diabetic and idiopathic gastroparesis.
Grover M; Dasari S; Bernard CE; Chikkamenahalli LL; Yates KP; Pasricha PJ; Sarosiek I; McCallum R; Koch KL; Abell TL; Kuo B; Shulman RJ; Gibbons SJ; McKenzie TJ; Kellogg TA; Kendrick ML; Tonascia J; Hamilton FA; Parkman HP; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G716-G726. PubMed ID: 31482734
[TBL] [Abstract][Full Text] [Related]
14. The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis.
Revicki DA; Lavoie S; Speck RM; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
J Patient Rep Outcomes; 2018 Dec; 2(1):61. PubMed ID: 30547386
[TBL] [Abstract][Full Text] [Related]
15. Direct health care costs associated with COVID-19 in the United States.
DeMartino JK; Swallow E; Goldschmidt D; Yang K; Viola M; Radtke T; Kirson N
J Manag Care Spec Pharm; 2022 Sep; 28(9):936-947. PubMed ID: 35722829
[No Abstract] [Full Text] [Related]
16. Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy.
Chung ES; Rickard J; Lu X; DerSarkissian M; Zichlin ML; Cheung HC; Swartz N; Greatsinger A; Duh MS
Adv Ther; 2021 Jan; 38(1):441-467. PubMed ID: 33141415
[TBL] [Abstract][Full Text] [Related]
17. Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes.
Weir MR; Chen YW; He J; Bookhart B; Campbell A; Ashton V
Diabetes Ther; 2021 Dec; 12(12):3167-3186. PubMed ID: 34699020
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
Strand V; Shah R; Atzinger C; Zhou J; Clewell J; Ganguli A; Tundia N
Curr Med Res Opin; 2020 Jan; 36(1):161-168. PubMed ID: 31433680
[No Abstract] [Full Text] [Related]
19. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
Bhowmik D; Hines DM; Intorcia M; Wade RL
J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
